Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
303 Leser
Artikel bewerten:
(1)

Sultan Capital Group Announces Strategic $20 Million PPE Partnership with Margma Malaysia

Affordable Medical-Grade Nitrile Exam Gloves to Be Distributed to US Market During 2021 Q1

NEW YORK, NY / ACCESSWIRE / January 5, 2021 / Today, Sultan Capital Group announced the signing of its agreement with Margma Malaysia to distribute personal protective equipment (PPE) in the United States. The strategic partnership will bring $20 million dollars' worth of nitrile examination gloves to be distributed by Margma over the first three months of 2021. The goal of the Sultan Capital Group is to support hospitals and private companies with a steady stream of the highest-grade PPE at a fair and affordable price.

"We are proud to have signed a significant deal with Margma for nitrile examination gloves and contributing a solution to the great need for PPE in the United States," said Guy Sultan, President of the Sultan Capital Group. "When we hear about the PPE shortages affecting American hospitals, the typical response is 'What are they going to do about it?' The 'they' are companies like ours. We are addressing the issue head-on. We provide the highest quality supplies to protect medical professionals from the virus that causes COVID-19. There is a great need for full protective gear in the US right now, especially with the current major surge in cases. Sultan Capital Group is committed to giving the US market access to protective gloves for frontline healthcare staff who come in contact with contagious individuals, often treating patients for 12-hour shifts."

In treating COVID-19 patients, medical staff must dispose of used gloves in-between patients, thoroughly wash their hands and then put on a new pair of gloves. Sultan added, "When you think of the enormity of the volume of supplies needed across the USA, it is obvious that importing $20 million worth of the best nitrile gloves will make a difference in the quality of working conditions and the safety of professionals, patients and families." Indeed, hospital staff fatigue and burnout are compounding the already serious challenges of containing the pandemic.

Sultan Capital Group has been a reliable leader with a solid reputation in the import industry since 2016. To date, they have supplied $7 million of medical supplies to hospitals and private medical facilities. This most recent deal was agreed to in response to the enormity of the global COVID-19 pandemic. Global conditions have presented the need for reliable and cost-effective PPE, especially as the pandemic continues far beyond what was originally expected. The coronavirus is far more contagious than public health organizations had originally thought, underscoring the necessity for quality PPE materials as vitally important to protect individuals from infection.

Personal protective equipment (PPE) is mandated when caring for patients with confirmed or suspected exposure to the Covid-19, and any infectious disease to present transmission between people. PPE must be of the highest standard and approved by quality control standard operating procedures. It is essential that equipment be used correctly, deliberately conforming to strict medical safety guidelines. Sultan Capital Group has demonstrated excellence in production of its nitrile examination gloves highlighting the Sultan Capital Group and its partner Margma as preferred vendors for PPE equipment.

For more information contact:

Guy@sultancapgroup.com

SOURCE: Sultan Capital Group



View source version on accesswire.com:
https://www.accesswire.com/622983/Sultan-Capital-Group-Announces-Strategic-20-Million-PPE-Partnership-with-Margma-Malaysia

© 2021 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.